Home E-Weekly April 17, 2018

News & Notes

Published: April 17, 2018

  • Exparel approved as post-op shoulder block Exparel has received FDA approval for use as an interscalene brachial plexus regional block. The bupivacaine liposome injectable suspension, which was originally approved by the FDA in 2011 as a single-dose analgesic shot at the surgical site, can now be used to manage post-op pain in patients undergoing upper-extremity surgeries, including shoulder arthroplasty and rotator cuff repair.
  • Health system billed outpatient cases an inpatient procedures Banner Health paid the United States more than $18 million to settle a False Claims Act allegation that 12 of its hospitals in Arizona and Colorado knowingly billed Medicare for more costly short-stay, inpatient procedures that should have been billed as outpatient procedures.
  • Vaginal mesh lawsuit A jury awarded a woman who claimed a vaginal mesh device implanted to treat pelvic organ prolapse left her in constant pain $35 million in punitive damages. The manufacture of that device, C.R. Bard, still faces another 150 lawsuits in state court as well more than 3,000 suits consolidated into a Federal case expected to go to trial next year.
New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

News & Notes

Jury: Spine ASC Discharged Patient Too Soon

News & Notes